Managing infectious diseases in wild populations involves difficult welfare trade-offs between controlling disease spread and the welfare of individual animals in management programs.
Wildlife disease management welfare involves genuine ethical complexity. Individual animals killed in disease management programs suffer clear welfare harm. The justification must rest on population-level or human health benefits that outweigh these individual harms. Badger culling welfare is particularly contested because the effectiveness evidence is ambiguous - welfare harm to individual badgers may not deliver the TB reduction benefits intended. Vaccination alternatives that achieve the same disease management objectives with far less individual welfare harm represent welfare-preferable approaches when feasible. Wildlife disease management decisions should explicitly include welfare impact assessments alongside epidemiological and economic analyses.